Trial Outcomes & Findings for Flavanol Augmentation for Antidepressant Non-Responsive Late Life Depression (NCT NCT02943096)

NCT ID: NCT02943096

Last Updated: 2019-09-06

Results Overview

Scale for depressive symptoms administered by trained rater. The HRSD is the standard measure of depression severity for clinical trials of antidepressants and was chosen as the primary outcome measure over other depression rating scales to ensure compatibility of study results with our meta-analyses and ongoing studies of expectancy. Although the HRSD list 21 items, the scoring is based on the first 24 items. The minimum score is 0 and the maximum score is 74. The higher the number the worse outcome.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

6 participants

Primary outcome timeframe

Week 8

Results posted on

2019-09-06

Participant Flow

We will recruit subjects via advertisements for patients who feel depressed, through the RecruitMe online platform, as well as clinical referrals from colleagues around CUMC.

Every subject evaluated for this protocol will receive a clinical interview by a psychiatrist or psychologist, be administered the 24-item Hamilton Rating Scale for Depression (HRSD) and Antidepressant Treatment History Form, and have a SCID performed by a trained rater. They will be educated about appropriate treatments available for depression.

Participant milestones

Participant milestones
Measure
Flavanol
Blinded treatment with either CocoaVia 500mg or placebo. CocoaVia: Flavanols represent a specific group of plant derived nutrients that are found in cocoa beans, grapes, tea, berries and various other fruits and vegetables. The specific flavanols investigated in this study come from cocoa.
Placebo
Blinded treatment with either CocoaVia 500mg or placebo. Placebo: The placebo looks like the other intervention pills, but does not contain any flavanols (it is sometimes called a "sugar pill").
Overall Study
STARTED
3
3
Overall Study
COMPLETED
3
2
Overall Study
NOT COMPLETED
0
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Flavanol
Blinded treatment with either CocoaVia 500mg or placebo. CocoaVia: Flavanols represent a specific group of plant derived nutrients that are found in cocoa beans, grapes, tea, berries and various other fruits and vegetables. The specific flavanols investigated in this study come from cocoa.
Placebo
Blinded treatment with either CocoaVia 500mg or placebo. Placebo: The placebo looks like the other intervention pills, but does not contain any flavanols (it is sometimes called a "sugar pill").
Overall Study
Lack of Efficacy
0
1

Baseline Characteristics

Flavanol Augmentation for Antidepressant Non-Responsive Late Life Depression

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Flavanol
n=3 Participants
Blinded treatment with either CocoaVia 500mg or placebo. CocoaVia: Flavanols represent a specific group of plant derived nutrients that are found in cocoa beans, grapes, tea, berries and various other fruits and vegetables. The specific flavanols investigated in this study come from cocoa.
Placebo
n=3 Participants
Blinded treatment with either CocoaVia 500mg or placebo. Placebo: The placebo looks like the other intervention pills, but does not contain any flavanols (it is sometimes called a "sugar pill").
Total
n=6 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Age, Categorical
>=65 years
2 Participants
n=5 Participants
3 Participants
n=7 Participants
5 Participants
n=5 Participants
Age, Continuous
71.8 years
STANDARD_DEVIATION 5.72 • n=5 Participants
75.2 years
STANDARD_DEVIATION 8.93 • n=7 Participants
73.5 years
STANDARD_DEVIATION 6.95 • n=5 Participants
Sex: Female, Male
Female
2 Participants
n=5 Participants
0 Participants
n=7 Participants
2 Participants
n=5 Participants
Sex: Female, Male
Male
1 Participants
n=5 Participants
3 Participants
n=7 Participants
4 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
3 Participants
n=5 Participants
3 Participants
n=7 Participants
6 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
White
2 Participants
n=5 Participants
3 Participants
n=7 Participants
5 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
3 participants
n=5 Participants
3 participants
n=7 Participants
6 participants
n=5 Participants
Hamilton Rating Scale for Depression
20 units on a scale
STANDARD_DEVIATION 1.73 • n=5 Participants
17 units on a scale
STANDARD_DEVIATION 8.72 • n=7 Participants
18.5 units on a scale
STANDARD_DEVIATION 5.86 • n=5 Participants

PRIMARY outcome

Timeframe: Week 8

Scale for depressive symptoms administered by trained rater. The HRSD is the standard measure of depression severity for clinical trials of antidepressants and was chosen as the primary outcome measure over other depression rating scales to ensure compatibility of study results with our meta-analyses and ongoing studies of expectancy. Although the HRSD list 21 items, the scoring is based on the first 24 items. The minimum score is 0 and the maximum score is 74. The higher the number the worse outcome.

Outcome measures

Outcome measures
Measure
Flavanol
n=3 Participants
Blinded treatment with either CocoaVia 500mg or placebo. CocoaVia: Flavanols represent a specific group of plant derived nutrients that are found in cocoa beans, grapes, tea, berries and various other fruits and vegetables. The specific flavanols investigated in this study come from cocoa.
Placebo
n=3 Participants
Blinded treatment with either CocoaVia 500mg or placebo. Placebo: The placebo looks like the other intervention pills, but does not contain any flavanols (it is sometimes called a "sugar pill").
Hamilton Rating Scale of Depression (HRSD)
18.3 score on a scale
Standard Deviation 6.43
20.3 score on a scale
Standard Deviation 2.08

SECONDARY outcome

Timeframe: Baseline

First, participants had to complete an encoding task were they were shown 128 items, ½ objects(2 seconds) and ½ scene (3 seconds). Right after, they were given instructions on a video on how to do the test phase. They were instructed to identified the following images as "old", "similar", or "new". They were then shown 192 items: 64 old items, 64 lures (similar), and 64 foil (new) for 2.5 seconds (objects)/3 seconds (scene). The images were intermixed during the test. The Lure Discrimination Index was calculated as the difference between the rate of "similar" responses give to lure items minus "similar" responses given to foil. This corrected for response bias. Correct responses are those that were identified correctly by the participant. A negative response means that the number of answered correctly was less that those answered incorrectly.

Outcome measures

Outcome measures
Measure
Flavanol
n=3 Participants
Blinded treatment with either CocoaVia 500mg or placebo. CocoaVia: Flavanols represent a specific group of plant derived nutrients that are found in cocoa beans, grapes, tea, berries and various other fruits and vegetables. The specific flavanols investigated in this study come from cocoa.
Placebo
n=3 Participants
Blinded treatment with either CocoaVia 500mg or placebo. Placebo: The placebo looks like the other intervention pills, but does not contain any flavanols (it is sometimes called a "sugar pill").
Mnemonic Similarity Task (MST)
-0.0567 Percent Endorsed
Standard Deviation .031
0.28 Percent Endorsed
Standard Deviation 0.178

SECONDARY outcome

Timeframe: Week 8

The ModBent assesses pattern separation, a measure of cognitive functioning. The task was created to measure dentate gyrus-dependent cognition. It shows participants patterns for 10 seconds, then presents two patterns afterwards on a different screen. Participants are then asked to determine which of the two patterns is the one they previously studied for 10 seconds. The second component of the task then goes through a series of patterns, one by one - the participant has to then decide whether each pattern was one they previously studied for 10 seconds or not. We analyzed the mean Reaction time for correct rejections.

Outcome measures

Outcome measures
Measure
Flavanol
n=3 Participants
Blinded treatment with either CocoaVia 500mg or placebo. CocoaVia: Flavanols represent a specific group of plant derived nutrients that are found in cocoa beans, grapes, tea, berries and various other fruits and vegetables. The specific flavanols investigated in this study come from cocoa.
Placebo
n=3 Participants
Blinded treatment with either CocoaVia 500mg or placebo. Placebo: The placebo looks like the other intervention pills, but does not contain any flavanols (it is sometimes called a "sugar pill").
Modified-Benton Task (ModBent)
5459.22 millisecond
Standard Deviation 592.67
5820.29 millisecond
Standard Deviation 675.79

SECONDARY outcome

Timeframe: Baseline

The ModBent assesses pattern separation, a measure of cognitive functioning. The task was created to measure dentate gyrus-dependent cognition. It shows participants patterns for 10 seconds, then presents two patterns afterwards on a different screen. Participants are then asked to determine which of the two patterns is the one they previously studied for 10 seconds. The second component of the task then goes through a series of patterns, one by one - the participant has to then decide whether each pattern was one they previously studied for 10 seconds or not. We analyzed the mean Reaction time for correct rejections.

Outcome measures

Outcome measures
Measure
Flavanol
n=3 Participants
Blinded treatment with either CocoaVia 500mg or placebo. CocoaVia: Flavanols represent a specific group of plant derived nutrients that are found in cocoa beans, grapes, tea, berries and various other fruits and vegetables. The specific flavanols investigated in this study come from cocoa.
Placebo
n=3 Participants
Blinded treatment with either CocoaVia 500mg or placebo. Placebo: The placebo looks like the other intervention pills, but does not contain any flavanols (it is sometimes called a "sugar pill").
Modified-Benton Task (ModBent)
4081.04 millisecond
Standard Deviation 412.17
6000.02 millisecond
Standard Deviation 403.67

SECONDARY outcome

Timeframe: Week 8

First, participants had to complete an encoding task were they were shown 128 items, ½ objects(2 seconds) and ½ scene (3 seconds). Right after, they were given instructions on a video on how to do the test phase. They were instructed to identified the following images as "old", "similar", or "new". They were then shown 192 items: 64 old items, 64 lures (similar), and 64 foil (new) for 2.5 seconds (objects)/3 seconds (scene). The images were intermixed during the test. The Lure Discrimination Index was calculated as the difference between the rate of "similar" responses give to lure items minus "similar" responses given to foil. This corrected for response bias. Correct responses are those that were identified correctly by the participant. A negative response means that the number of answered correctly was less that those answered incorrectly.

Outcome measures

Outcome measures
Measure
Flavanol
n=3 Participants
Blinded treatment with either CocoaVia 500mg or placebo. CocoaVia: Flavanols represent a specific group of plant derived nutrients that are found in cocoa beans, grapes, tea, berries and various other fruits and vegetables. The specific flavanols investigated in this study come from cocoa.
Placebo
n=3 Participants
Blinded treatment with either CocoaVia 500mg or placebo. Placebo: The placebo looks like the other intervention pills, but does not contain any flavanols (it is sometimes called a "sugar pill").
Mnemonic Similarity Task (MST)
0.15 Percent Endorsed
Standard Deviation 0.32
.61 Percent Endorsed
Standard Deviation 0.29

Adverse Events

Flavanol

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Placebo

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Bret R. Rutherford

New York State Psychiatric Institute

Phone: 646-774-8660

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place